- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SCANDIDOS Aktie jetzt für 0€ handeln | |||||
| 22.06. | Listing of subscription rights and paid subscription shares of ScandiDos AB | 242 | GlobeNewswire | With effect from June 23, 2026, the subscription rights in ScandiDos AB will be traded on First North Growth Market. Trading will continue up until and including July 06, 2026.
Instrument:
Subscription... ► Artikel lesen | |
| 17.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.06.2026 | 409 | Xetra Newsboard | Das Instrument EA20 NO0013601245 EAM SOLAR AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 17.06.2026 und ex Kapitalmassnahme am 18.06.2026 The instrument EA20 NO0013601245 EAM SOLAR AS NK... ► Artikel lesen | |
| 06.05. | ScandiDos AB: Anders Murman appointed Acting CEO of ScandiDos | 495 | GlobeNewswire (Europe) | ScandiDos AB announces that Gustaf Piehl is stepping down as Chief Executive Officer at his own request. The Board has appointed Anders Murman as Acting CEO, effective 6 May 2026. A process to recruit... ► Artikel lesen | |
| 13.02. | The observation status for ScandiDos AB is removed | 349 | GlobeNewswire | On November 14, 2025, the shares in ScandiDos AB (the "Company") were given observation status with reference to a mandatory public offer from Spore Invest AB to the other shareholders of the Company.
On... ► Artikel lesen | |
| 14.11.25 | ScandiDos AB receives observation status | 381 | GlobeNewswire | Today, November 14, 2025, Spore Invest AB disclosed a mandatory public offer to the other shareholders in ScandiDos AB.
The rules of Nasdaq First North Growth Market state that an issuer may... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 49,890 | 0,00 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,22 | -0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 25,820 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,590 | 0,00 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| FRESENIUS | 46,415 | +1,24 % | Fresenius macht weitere 300 Millionen Euro bei FMC zu Geld | Fresenius trennt sich von weiteren 7,8 Millionen Aktien der Fresenius Medical Care (FMC) und erlöst damit rund 300 Millionen Euro. Das Paket entspricht etwa 2,9 Prozent des ausgegebenen FMC-Grundkapitals... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 7,190 | 0,00 % | Autonomix Medical more than doubles after $4.9M warrant deal; shares hit $11.63 | ||
| BILLIONTOONE | 100,02 | -0,06 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PICARD MEDICAL | 9,500 | -0,31 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen | |
| GENEDX | 87,44 | +0,04 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs | ||
| LIFESTANCE HEALTH GROUP | 12,280 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,595 | +0,04 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,560 | -0,35 % | Siemens-Healthineers-Chef: 'Mir gefällt dieses Rumgenörgel nicht' | BERLIN (dpa-AFX) - Der Vorstandvorsitzende des Dax -Konzerns Siemens Healthineers, Bernhard Montag, hat die Anspruchshaltung vieler Wirtschaftslenker in Deutschland gegenüber der Politik kritisiert.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,740 | +0,94 % | Fresenius senkt Beteiligung an FMC weiter | BAD HOMBURG (dpa-AFX) - Der Gesundheitskonzern Fresenius reduziert seinen Anteil an dem Dialyseunternehmen Fresenius Medical Care (FMC ). Es verkauft 7,8 Millionen Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| CLEARPOINT NEURO | 16,990 | +0,18 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,200 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
SCANDIDOS AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,002 (-3,06 %) liegt der Kurs bei 0,048 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDIDOS AB finden Sie auf Wallstreet Online.